Angiocentrum Komořany
- Address
- lock Available on a paid plan
Cardiovascular Diseases
At Angiocentrum Komořany in Praha, clinical research in cardiovascular diseases focuses on major conditions such as atherosclerotic cardiovascular disease and elevated lipoprotein(a). The trials are designed to assess whether new treatments can better reduce the risk of serious heart and blood vessel events and improve prevention for patients at higher cardiovascular risk.
- Research on atherosclerotic cardiovascular disease and related risk reduction
- Studies in elevated lipoprotein(a) as a contributor to heart disease
- Evaluation of new therapies aimed at lowering major cardiovascular event risk
These studies are centered on testing treatment effectiveness and advancing preventive care for people with significant cardiovascular risk factors.
Respiratory Tract Diseases
Clinical trial activity at this site also includes research linked to respiratory tract diseases, with an emphasis on hypertension in people who are overweight or living with obesity. The goal is to evaluate whether new treatment approaches can help manage blood pressure more effectively and support broader cardiometabolic health.
- Investigation of hypertension in participants with obesity or overweight
- Assessment of treatment options that may improve blood pressure control
- Research supporting better care for patients with overlapping cardiovascular and metabolic risks
The work at Angiocentrum Komořany is aimed at building evidence for safer and more effective therapies in everyday clinical practice.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.